| scholarly article | Q13442814 |
| P2093 | author name string | Gao C | |
| Miyazaki M | |||
| Inoue Y | |||
| Shimizu N | |||
| Tsuji T | |||
| Namba M | |||
| Hamazaki K | |||
| Ohashi R | |||
| Uemura T | |||
| Hirai R | |||
| P433 | issue | 1B | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 657-662 | |
| P577 | publication date | 2001-01-01 | |
| P1433 | published in | Anticancer Research | Q326290 |
| P1476 | title | Enhanced expression of cyclin E and cyclin A in human hepatocellular carcinomas | |
| P478 | volume | 21 |
| Q64899142 | Blocking CDK1/PDK1/β-Catenin signaling by CDK1 inhibitor RO3306 increased the efficacy of sorafenib treatment by targeting cancer stem cells in a preclinical model of hepatocellular carcinoma. |
| Q57817291 | Clinical significance and biological roles of cyclins in gastric cancer |
| Q36612365 | Clinicopathological significance of homeoprotein Six1 in hepatocellular carcinoma |
| Q36693257 | Cyclin A2 and CDK2 as Novel Targets of Aspirin and Salicylic Acid: A Potential Role in Cancer Prevention |
| Q37662178 | Drp1-mediated mitochondrial fission promotes cell proliferation through crosstalk of p53 and NF-κB pathways in hepatocellular carcinoma |
| Q90383817 | Experimental Models to Define the Genetic Predisposition to Liver Cancer |
| Q36308826 | Expression of p27, cyclin E and cyclin A in hepatocellular carcinoma and its clinical significance |
| Q64229414 | Network Pharmacology and Bioinformatics Approach Reveals the Therapeutic Mechanism of Action of Baicalein in Hepatocellular Carcinoma |
| Q42257574 | Overexpression of cyclin E in Mongolian gerbil with Helicobacter pylori-induced gastric precancerosis |
| Q35810123 | Recent progress in predictive biomarkers for metastatic recurrence of human hepatocellular carcinoma: a review of the literature |
| Q35273519 | SKP2 cooperates with N-Ras or AKT to induce liver tumor development in mice |
| Q36447664 | Small Molecule Modulators of Pre-mRNA Splicing in Cancer Therapy |
| Q59328880 | Suppression of Hepatic Bile Acid Synthesis by a non-tumorigenic FGF19 analogue Protects Mice from Fibrosis and Hepatocarcinogenesis |
| Q33965228 | TGF-beta inactivation and TGF-alpha overexpression cooperate in an in vivo mouse model to induce hepatocellular carcinoma that recapitulates molecular features of human liver cancer |
| Q34668320 | The prognostic molecular markers in hepatocellular carcinoma |
Search more.